Latest Biotechnology Commercialisation News

Page 1 of 1

Starpharma Secures $3.7M Boost from R&D Tax Incentive for 2025

Starpharma has received a $3.7 million R&D Tax Incentive refund for the 2025 financial year, reinforcing its commitment to advancing dendrimer technology and biotechnology innovation in Australia.

Ada Torres

28 Aug 2025

Top